Carlota Gudiol
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 21
- Clinical Biochemistry top 0.2%
- Bacterial Identification and Susceptibility Testing 21
- Infectious Diseases top 1%
- Antifungal resistance and susceptibility 19
- Oncology top 2%
- Neutropenia and Cancer Infections 37
-
- Antibiotics Pharmacokinetics and Efficacy 15
-
- Pneumocystis jirovecii pneumonia detection and treatment 12
- Pneumonia and Respiratory Infections 11
- Fungal Infections and Studies 11
- Co-authors
- Jordi CarratalàCarolina García‐VidalMontserrat ArnánRafael F. DuarteFé TubauCarmen ArdanuyM. CisnalIsabel Sánchez‐Ortega
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Carlota Gudiol
93 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 107
- Molecular Medicine 746
- Applied Microbiology and Biotechnology 285
- Clinical Biochemistry 830
- Infectious Diseases 1.0k
- Oncology 1.2k
Countries citing papers authored by Carlota Gudiol
This map shows the geographic impact of Carlota Gudiol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlota Gudiol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlota Gudiol more than expected).
Fields of papers citing papers by Carlota Gudiol
This network shows the impact of papers produced by Carlota Gudiol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlota Gudiol. The network helps show where Carlota Gudiol may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carlota Gudiol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 9 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 35 | |
| 11 | 2021 | 3 | |
| 12 | 2020 | 4 | |
| 13 | 2020 | 14 | |
| 14 | 2020 | 6 | |
| 15 | 2020 | 28 | |
| 16 | 2019 | 26 | |
| 17 | 2018 | 11 | |
| 18 | 2018 | 17 | |
| 19 | 2015 | 22 | |
| 20 | 2014 | 18 |
About Carlota Gudiol
Carlota Gudiol is a scholar working on Molecular Medicine, Clinical Biochemistry and Applied Microbiology and Biotechnology, having authored 95 papers that have together received 3.1k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (37 papers), Antibiotic Resistance in Bacteria (21 papers), Bacterial Identification and Susceptibility Testing (21 papers), Antifungal resistance and susceptibility (19 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers), Pneumocystis jirovecii pneumonia detection and treatment (12 papers), Pneumonia and Respiratory Infections (11 papers) and Fungal Infections and Studies (11 papers). The work is most often cited by research in Molecular Medicine (746 citations), Applied Microbiology and Biotechnology (285 citations) and Clinical Biochemistry (830 citations). Carlota Gudiol has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Jordi Carratalà, Carolina García‐Vidal, Montserrat Arnán, Rafael F. Duarte, Fé Tubau, Carmen Ardanuy, M. Cisnal, Isabel Sánchez‐Ortega, Laura Calatayud and Guillermo Cuervo. Their work appears in journals such as Nature Communications, PLoS ONE and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.